Treatment for Triple Negative Breast Cancer: An Update
Please join us for our next on-line seminar for people affected by hereditary breast and ovarian cancer.
July 20, 2010
Presented by Melinda Telli, MD.; Acting Assistant Professor; Division of Oncology; Stanford University School of Medicine; Stanford, CA. This session focuses on specific groups of women who are likely to develop TNBC; features of TNBC that make it unique and challenging to treat; and emerging and promising treatment options for TNBC.
Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.
This site has been made possible by a generous grant from Morphotek.